Medpace Holdings (MEDP) Equity Ratio (2015 - 2026)

Medpace Holdings has reported Equity Ratio for 12 years, with the latest figure at 0.28 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio fell 10.2% year-over-year to 0.28; the trailing twelve-month figure through Mar 2026 stood at 0.28 (down 10.2% YoY), and the FY2025 full-year result was 0.23, down 40.86% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.28, up from 0.23 in the prior quarter.
• The five-year high for Equity Ratio was 0.45 in Q1 2022, with the low at 0.11 in Q2 2025.
• Historically, Equity Ratio has averaged 0.3 across 5 years, with a median of 0.29 in 2022.
• Annual changes were most pronounced in 2024 — Equity Ratio jumped 50.3% — and 2025, when it slumped 72.43%.
• Medpace Holdings' Equity Ratio stood at 0.29 in 2022, then rose by 18.09% to 0.34 in 2023, then gained by 16.48% to 0.39 in 2024, then slumped by 40.86% to 0.23 in 2025, then increased by 20.9% to 0.28 in 2026.
• The last three Equity Ratio figures came in at 0.28 (Q1 2026), 0.23 (Q4 2025), and 0.17 (Q3 2025), per Business Quant data.